Recombinant gp350 Vaccine for Infectious Mononucleosis: A Phase 2, Randomized, Double‐Blind, Placebo‐Controlled Trial to Evaluate the Safety, Immunogenicity, and Efficacy of an Epstein‐Barr Virus Vaccine in Healthy Young Adults
2007 ◽
Vol 196
(12)
◽
pp. 1749-1753
◽
Keyword(s):
Phase 2
◽
Keyword(s):
2007 ◽
Vol 196
(12)
◽
pp. 1724-1726
◽
Keyword(s):
2003 ◽
Vol 131
(1)
◽
pp. 683-689
◽
Keyword(s):
Keyword(s):
2010 ◽
Vol 50
(7)
◽
pp. 734-742
◽
Keyword(s):
Keyword(s):
2018 ◽